```html

Ileitis – A Complete Patient‑Friendly Guide

Overview

Ileitis is inflammation of the ileum, the final and longest segment of the small intestine (the distal 3‑foot portion that empties into the colon at the ileocecal valve). The condition can be isolated (affecting only the ileum) or part of a broader disease process such as Crohn’s disease, ulcerative colitis, infections, or medication‑induced injury.

Who it affects: Ileitis can occur at any age, but the most common patterns are:

• Young adults (15‑35 years) – especially those who develop Crohn’s disease.
• Children and adolescents – 10–20% of pediatric inflammatory bowel disease (IBD) cases involve the ileum.
• Elderly patients – often related to infections (e.g., Yersinia, tuberculosis) or drug toxicity.

Prevalence: Precise population data for isolated ileitis are limited, but estimates from the United States and Europe suggest:

• Approximately 3–5 per 100,000 people have Crohn’s disease limited to the ileum (aka “ileal Crohn’s”).
• Infections causing ileitis (e.g., Yersinia, Campylobacter) affect 0.5–1 per 1,000 individuals annually, often under‑reported.

Overall, ileitis is a relatively uncommon condition, yet it is a key component of several more common gastrointestinal disorders.

Symptoms

Symptoms can vary from mild, intermittent discomfort to severe, disabling pain. The following list captures the most frequent manifestations, each accompanied by a brief description.

Abdominal Pain & Cramping

• Usually localized in the lower right quadrant (RLQ) where the ileum resides.
• Often described as a dull, colicky pain that may worsen after meals.

Diarrhea

• Watery or loose stools, sometimes with urgency.
• If inflammation is severe, stools may contain mucus or blood.

Weight Loss & Malnutrition

• Result of malabsorption of fats, vitamins (B12, D, K), and minerals.
• Unexplained weight loss of >5% body weight over 6–12 months should raise concern.

Fatigue

• Secondary to chronic inflammation, anemia, or nutrient deficiencies.

Nausea & Vomiting

• More common when the ileum is severely inflamed or obstructed.

Fever & Chills

• Indicative of an infectious cause (e.g., Yersinia, tuberculosis) or a flare of inflammatory disease.

Joint or Skin Symptoms

• Extra‑intestinal manifestations (e.g., erythema nodosum, arthritis) often accompany Crohn’s‑related ileitis.

Perianal Disease

• Fistulas or abscesses are possible when ileitis is part of Crohn’s disease.

Causes and Risk Factors

Ileitis is not a single disease; it is a descriptive term for inflammation of the ileum. The underlying causes can be grouped into three categories.

Inflammatory Bowel Disease (IBD)

• Crohn’s disease – the most common cause of chronic ileitis; up to 70% of Crohn’s patients have ileal involvement.
• Genetic predisposition (NOD2, ATG16L1, IRGM genes).
• Family history of IBD (first‑degree relative increases risk 2–5×).
• Smoking doubles the risk of Crohn’s disease and worsens ileal disease.

Infectious Agents

• Yersinia enterocolitica – mimics Crohn’s with terminal ileum inflammation.
• Mycobacterium tuberculosis – ileal TB often presents with ulcerations and strictures.
• Campylobacter, Salmonella, Shigella – acute bacterial gastroenteritis may extend to the ileum.
• Parasites – e.g., Giardia lamblia can cause chronic ileitis.

Medication‑Induced or Other Causes

• Non‑steroidal anti‑inflammatory drugs (NSAIDs) – especially in patients with underlying IBD.
• Radiation enteritis after pelvic/abdominal radiation therapy.
• Ischemia (mesenteric vascular disease) – rare but possible in elderly patients.
• Autoimmune conditions (e.g., sarcoidosis).

Risk Factors Summary

• Age 15‑35 (peak for Crohn’s ileitis)
• Positive family history of IBD
• Current or former smoker
• Recent travel to regions with endemic Yersinia or TB
• Chronic NSAID use

Diagnosis

Diagnosing ileitis requires a combination of clinical evaluation, laboratory testing, and imaging or endoscopic studies. The goal is to identify the underlying cause and assess disease severity.

Clinical Evaluation

• Detailed medical history (symptom pattern, medication use, travel, family history).
• Physical exam focusing on abdominal tenderness (especially RLQ), presence of masses, and extra‑intestinal signs.

Laboratory Tests

• Complete blood count (CBC) – looks for anemia, leukocytosis.
• Inflammatory markers: C‑reactive protein (CRP) and erythrocyte sedimentation rate (ESR).
• Stool studies – culture, O&P, PCR for pathogens (Yersinia, C. difficile), fecal calprotectin (elevated in IBD).
• Serologic tests – anti‑Saccharomyces cerevisiae antibodies (ASCA) may support Crohn’s; interferon‑γ release assay (IGRA) for TB.
• Vitamin B12, folate, iron studies – assess malabsorption.

Imaging & Endoscopy

• Magnetic Resonance Enterography (MRE) – non‑invasive, excellent for visualizing ileal wall thickening, strictures, and fistulas; no radiation.
• CT Enterography – quicker, useful in acute settings; provides detailed cross‑sectional images.
• Small‑Bowel Follow‑Through (SBFT) – barium study; less commonly used now.
• Ileocolonoscopy – gold standard for direct visualization and biopsy; can assess both ileum and colon simultaneously.
• Biopsy results – granulomas (Crohn’s), acid‑fast bacilli (TB), or neutrophilic infiltrates (infectious).

Additional Tests (When Indicated)

• Capsule endoscopy – useful when colonoscopy is negative but suspicion remains high; contraindicated if strictures are present.
• Radiolabeled white‑blood‑cell scan – localizes active inflammation in select cases.

Treatment Options

Treatment is tailored to the underlying cause, disease severity, and patient preferences.

1. Inflammatory Bowel Disease–Related Ileitis

• Induction therapy (to achieve remission):
  • Corticosteroids – oral prednisone (40–60 mg daily) or budesonide (targeted release) for 6–8 weeks.
  • Biologic agents – anti‑TNF (infliximab, adalimumab), anti‑integrin (vedolizumab), anti‑IL‑12/23 (ustekinumab).
  • Small‑molecule drugs – Janus kinase (JAK) inhibitors (tofacitinib) for selected patients.
• Maintenance therapy (to keep remission):
  • Immunomodulators – azathioprine, 6‑mercaptopurine, methotrexate.
  • Continued biologic or JAK inhibitor therapy at scheduled intervals.
• Nutritional support:
  • Enteral nutrition (elemental formulas) can induce remission, especially in pediatric cases.
  • Vitamin B12 injections for malabsorption.

2. Infectious Ileitis

• Yersinia – usually self‑limited; severe cases receive fluoroquinolones** (ciprofloxacin 500 mg BID 5–7 days) or **trimethoprim‑sulfamethoxazole**.
• Mycobacterium tuberculosis – standard 6‑month anti‑TB regimen (isoniazid, rifampin, pyrazinamide, ethambutol).
• Other bacterial infections – targeted antibiotics based on culture/sensitivity.
• Parasitic infections – metronidazole for Giardia, etc.

3. Medication‑Induced Ileitis

• Discontinue the offending NSAID or drug.
• Short course of oral steroids (e.g., prednisone 20‑40 mg) if inflammation persists.
• Proton‑pump inhibitors or misoprostol may be used for NSAID‑related ulceration.

4. Surgical Options

• Indications: strictures causing obstruction, fistulas, perforation, refractory disease, or cancer suspicion.
• Procedures:
  • Strictureplasty – widens narrowed ileal segments while preserving bowel length.
  • Resection with primary anastomosis – removes diseased segment (often ~30‑50 cm).
  • Subtotal colectomy with ileorectal anastomosis – for extensive disease.
• Laparoscopic approaches have become standard for most elective cases, offering faster recovery.

5. Lifestyle & Supportive Measures

• Stop smoking – improves response to medical therapy and lowers recurrence.
• Balanced diet rich in lean protein, low‑residue foods during flares, and adequate hydration.
• Regular exercise (moderate aerobic activity 150 min/week) improves gut motility and mood.
• Stress‑management techniques (mindfulness, CBT) – shown to reduce IBD flare frequency.

Living with Ileitis

Managing ileitis is a day‑to‑day partnership between you, your gastroenterologist, and your support network.

Nutrition Tips

• Small, frequent meals – reduces post‑prandial pain.
• Low‑FODMAP diet – may lessen bloating and diarrhea in some patients (consult a dietitian).
• Supplement Vitamin B12, vitamin D, calcium, and iron if labs show deficiency.
• Avoid high‑fat, fried foods and excessive caffeine, which can aggravate diarrhea.

Medication Adherence

• Use a pill‑box or smartphone reminders.
• Keep a symptom diary; note any new side effects promptly.
• Never stop biologic infusions without discussing a transition plan.

Monitoring & Follow‑Up

• Regular labs every 3–6 months (CBC, CRP, liver/kidney function).
• Endoscopic surveillance every 1–3 years for dysplasia, especially if disease duration >8–10 years.
• Imaging (MRE) if new pain, obstruction signs, or suspicion of fistula.

Psychosocial Support

• Consider joining IBD support groups (Crohn’s & Colitis Foundation).
• Seek counseling if anxiety or depression interferes with daily life.
• Workplace accommodations: flexible breaks, easy restroom access.

Prevention

Because many cases of ileitis are linked to chronic disease (Crohn’s) or infections, absolute prevention is not always possible, but risk can be reduced.

• Smoking cessation – the single most effective modifiable factor.
• Practice safe food handling: cook meats thoroughly, wash fruits/vegetables, avoid unpasteurized dairy.
• Travel hygiene: use bottled water, avoid raw salads in high‑risk regions.
• Limit NSAID use; opt for acetaminophen or COX‑2‑selective agents if analgesia is needed.
• Maintain up‑to‑date vaccinations (TB skin test, hepatitis B) for at‑risk patients.
• Early treatment of GI infections – seek medical care for persistent fever, bloody diarrhea, or severe abdominal pain.

Complications

If ileitis is not adequately controlled, a range of complications may develop.

• Intestinal obstruction – due to strictures or adhesions; may require surgery.
• Fistula formation – abnormal connections to the bladder, skin, or other bowel loops.
• Malabsorption syndromes – chronic B12 deficiency leading to megaloblastic anemia, osteopenia from calcium/vitamin D loss.
• Growth failure in children – due to nutrient loss and chronic inflammation.
• Increased cancer risk – long‑standing ileal Crohn’s raises the odds of small‑bowel adenocarcinoma (approximately 2–3‑fold).
• Sepsis – particularly with perforation or severe infection.

When to Seek Emergency Care

Call 911 or go to the nearest emergency department if you experience any of the following:

• Sudden, severe abdominal pain that does not improve with usual pain medication.
• Persistent vomiting (more than 2–3 times) or inability to keep fluids down.
• Bloody diarrhea (bright red or “tarry” black stools).
• High fever (≥38.5 °C / 101.3 °F) with chills.
• Signs of dehydration: dizziness, scant urine, rapid heartbeat.
• Sudden swelling of the abdomen or a feeling of “fullness” after a small meal (possible obstruction).
• Unexplained rapid weight loss (>10 lb/4.5 kg in a month) combined with weakness.
• New onset of severe joint swelling, shortness of breath, or chest pain (possible systemic complications).

Prompt evaluation can prevent life‑threatening complications such as perforation or sepsis.

---

Sources: Mayo Clinic, Crohn’s & Colitis Foundation, CDC Infectious Disease Guidelines, American College of Gastroenterology (ACG) Clinical Guidelines, National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK), WHO Tuberculosis Fact Sheets, peer‑reviewed articles in Gastroenterology and Inflammatory Bowel Diseases journal (2022‑2024).

```